350 related articles for article (PubMed ID: 32070547)
1. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle.
Fang L; Lin H; Wu Z; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Carbohydr Polym; 2020 Apr; 234():115930. PubMed ID: 32070547
[TBL] [Abstract][Full Text] [Related]
2. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
[TBL] [Abstract][Full Text] [Related]
3. Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.
Peng N; Yu H; Yu W; Yang M; Chen H; Zou T; Deng K; Huang S; Liu Y
Acta Biomater; 2020 Mar; 105():223-238. PubMed ID: 31926335
[TBL] [Abstract][Full Text] [Related]
4. Reduction-Responsive and Multidrug Deliverable Albumin Nanoparticles: An Antitumor Drug to Abraxane against Human Pancreatic Tumor-Bearing Mice.
Hirakawa N; Ishima Y; Kinoshita R; Nakano R; Chuang VTG; Ando H; Shimizu T; Okuhira K; Maruyama T; Otagiri M; Ishida T
ACS Appl Bio Mater; 2021 May; 4(5):4302-4309. PubMed ID: 35006842
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment Responsive Shape-Reversal Self-Targeting Virus-Inspired Nanodrug for Imaging-Guided Near-Infrared-II Photothermal Chemotherapy.
Li Y; Lin J; Wang P; Luo Q; Lin H; Zhang Y; Hou Z; Liu J; Liu X
ACS Nano; 2019 Nov; 13(11):12912-12928. PubMed ID: 31651142
[TBL] [Abstract][Full Text] [Related]
6. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
[TBL] [Abstract][Full Text] [Related]
7. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.
Wang H; Zhang F; Wen H; Shi W; Huang Q; Huang Y; Xie J; Li P; Chen J; Qin L; Zhou Y
J Nanobiotechnology; 2020 Jan; 18(1):8. PubMed ID: 31918714
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
[TBL] [Abstract][Full Text] [Related]
9. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
10. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
Xiong H; Wu Y; Jiang Z; Zhou J; Yang M; Yao J
J Colloid Interface Sci; 2019 Feb; 536():135-148. PubMed ID: 30366179
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways.
Song J; Lin C; Yang X; Xie Y; Hu P; Li H; Zhu W; Hu H
J Control Release; 2019 Jan; 294():27-42. PubMed ID: 30445003
[TBL] [Abstract][Full Text] [Related]
12. Multifunction in One Molecule: Mitochondrial Imaging and Photothermal & Photodynamic Cytotoxicity of Fast-Response Near-Infrared Fluorescent Probes with Aggregation-Induced Emission Characteristics.
Zhang L; Wang JL; Ba XX; Hua SY; Jiang P; Jiang FL; Liu Y
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7945-7954. PubMed ID: 33588525
[TBL] [Abstract][Full Text] [Related]
13. Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect.
Guo C; Hou X; Liu Y; Zhang Y; Xu H; Zhao F; Chen D
Phytomedicine; 2021 Jan; 80():153356. PubMed ID: 33039729
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation.
Feng L; Xie R; Wang C; Gai S; He F; Yang D; Yang P; Lin J
ACS Nano; 2018 Nov; 12(11):11000-11012. PubMed ID: 30339353
[TBL] [Abstract][Full Text] [Related]
15. Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate-mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects.
Fan Z; Wang Y; Xiang S; Zuo W; Huang D; Jiang B; Sun H; Yin W; Xie L; Hou Z
J Mater Chem B; 2020 Mar; 8(9):1922-1934. PubMed ID: 32052817
[TBL] [Abstract][Full Text] [Related]
16. Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer.
Ma Q; Qian W; Tao W; Zhou Y; Xue B
Drug Des Devel Ther; 2019; 13():4021-4033. PubMed ID: 31819373
[TBL] [Abstract][Full Text] [Related]
17. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity.
Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled Angelica sinensis polysaccharide nanoparticles with an instinctive liver-targeting ability as a drug carrier for acute alcoholic liver damage protection.
Wang K; Xu J; Liu Y; Cui Z; He Z; Zheng Z; Huang X; Zhang Y
Int J Pharm; 2020 Mar; 577():118996. PubMed ID: 31904402
[TBL] [Abstract][Full Text] [Related]
19. Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer.
MacCuaig WM; Fouts BL; McNally MW; Grizzle WE; Chuong P; Samykutty A; Mukherjee P; Li M; Jasinski JB; Behkam B; McNally LR
ACS Appl Mater Interfaces; 2021 Oct; 13(42):49614-49630. PubMed ID: 34653338
[TBL] [Abstract][Full Text] [Related]
20. "Watson-Crick G[triple bond, length as m-dash]C"-inspired supramolecular nanodrug of methotrexate and 5-fluorouracil for tumor microenvironment-activatable self-recognizing synergistic chemotherapy.
Chen M; Chen S; Zhu F; Wang F; Tian H; Fan Z; Ke S; Hou Z; Li Y
J Mater Chem B; 2020 May; 8(17):3829-3841. PubMed ID: 32232285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
